Funabashi, Japan

Miyako Kamon



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Miyako Kamon

Introduction

Miyako Kamon is a prominent inventor based in Funabashi, Japan. She has made significant contributions to the field of pharmaceuticals through her innovative research and development. Her work focuses on the creation of new drug compounds that have the potential to improve health outcomes.

Latest Patents

Miyako Kamon holds a patent for a crystal form of a tricyclic benzopyran compound, specifically titled "Crystal form of (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol and production method thereof." This patent describes crystal forms that are excellent as a drug, along with various production methods. These methods include crystallizing the compound from different types of solvents, such as acetate ester, aliphatic hydrocarbon, nitrile, aromatic hydrocarbon, ketone, or ether solvents.

Career Highlights

Miyako Kamon is currently employed at Nissan Chemical Industries Limited, where she continues to advance her research in drug development. Her work has led to the creation of innovative compounds that have the potential to be used in therapeutic applications.

Collaborations

Miyako collaborates with esteemed colleagues, including Yasutaka Takada and Shiro Kawahara. Their combined expertise contributes to the success of their research projects and the development of new pharmaceutical solutions.

Conclusion

Miyako Kamon is a trailblazer in the field of pharmaceutical innovation, with her patent highlighting her contributions to drug development. Her work at Nissan Chemical Industries Limited and collaborations with fellow researchers underscore her commitment to advancing healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…